Literature DB >> 33345392

Dissecting molecular details and functional effects of the high-affinity copper binding site in plasminogen activator Inhibitor-1.

Yuzhuo Chu1, Joel C Bucci1, Cynthia B Peterson1.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor for plasminogen activators, tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). As a unique member in the serine protease inhibitor (serpin) family, PAI-1 is metastable and converts to an inactive, latent structure with a half-life of 1-2 hr under physiological conditions. Unusual effects of metals on the rate of the latency conversion are incompletely understood. Previous work has identified two residues near the N-terminus, H2 and H3, which reside in a high-affinity copper-binding site in PAI-1 [Bucci JC, McClintock CS, Chu Y, Ware GL, McConnell KD, Emerson JP, Peterson CB (2017) J Biol Inorg Chem 22:1123-1,135]. In this study, neighboring residues, H10, E81, and H364, were tested as possible sites that participate in Cu(II) coordination at the high-affinity site. Kinetic methods, gel sensitivity assays, and isothermal titration calorimetry (ITC) revealed that E81 and H364 have different roles in coordinating metal and mediating the stability of PAI-1. H364 provides a third histidine in the metal-coordination sphere with H2 and H3. In contrast, E81 does not appear to be required for metal ligation along with histidines; contacts made by the side-chain carboxylate upon metal binding are perturbed and, in turn, influence dynamic fluctuations within the region encompassing helices D, E, and F and the W86 loop that are important in the pathway for the PAI-1 latency conversion. This investigation underscores a prominent role of protein dynamics, noncovalent bonding networks and ligand binding in controlling the stability of the active form of PAI-1.
© 2020 The Protein Society.

Entities:  

Keywords:  PAI-1; calorimetry; copper; stability

Mesh:

Substances:

Year:  2021        PMID: 33345392      PMCID: PMC7888543          DOI: 10.1002/pro.4017

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  52 in total

1.  Structural basis for serpin inhibitor activity.

Authors:  H T Wright; J N Scarsdale
Journal:  Proteins       Date:  1995-07

2.  CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data.

Authors:  Jing Huang; Alexander D MacKerell
Journal:  J Comput Chem       Date:  2013-07-06       Impact factor: 3.376

3.  Stability of plasminogen activator inhibitor 1 (PAI-1).

Authors:  T L Lindahl; O Sigurdardottir; B Wiman
Journal:  Thromb Haemost       Date:  1989-09-29       Impact factor: 5.249

4.  Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.

Authors:  S T Olson; R Swanson; D Day; I Verhamme; J Kvassman; J D Shore
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

5.  Structures of active and latent PAI-1: a possible stabilizing role for chloride ions.

Authors:  T J Stout; H Graham; D I Buckley; D J Matthews
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

Review 6.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

7.  The reactive-center loop of active PAI-1 is folded close to the protein core and can be partially inserted.

Authors:  Peter Hägglöf; Fredrik Bergström; Malgorzata Wilczynska; Lennart B-A Johansson; Tor Ny
Journal:  J Mol Biol       Date:  2004-01-16       Impact factor: 5.469

8.  Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease.

Authors:  C H Lundgren; S L Brown; T K Nordt; B E Sobel; S Fujii
Journal:  Circulation       Date:  1996-01-01       Impact factor: 29.690

Review 9.  Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

Authors:  Michelle K V Durand; Julie S Bødker; Anni Christensen; Daniel M Dupont; Martin Hansen; Jan K Jensen; Signe Kjelgaard; Lisa Mathiasen; Katrine E Pedersen; Sune Skeldal; Troels Wind; Peter A Andreasen
Journal:  Thromb Haemost       Date:  2004-03       Impact factor: 5.249

10.  Conformational preludes to the latency transition in PAI-1 as determined by atomistic computer simulations and hydrogen/deuterium-exchange mass spectrometry.

Authors:  Michael Petersen; Jeppe B Madsen; Thomas J D Jørgensen; Morten B Trelle
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

View more
  1 in total

1.  Dissecting molecular details and functional effects of the high-affinity copper binding site in plasminogen activator Inhibitor-1.

Authors:  Yuzhuo Chu; Joel C Bucci; Cynthia B Peterson
Journal:  Protein Sci       Date:  2021-01-13       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.